Advertisement
News
Subscribe to MDT Magazine News

Meyer Burger receives order for diamond-wire saws from Monocrystal

May 11, 2011 2:42 pm | by I-Micronews | Comments

Meyer Burger with strategic important order from Monocrystal ? a worldwide leading manufacturer of sapphire crystals and wafers in optoelectronics.

Mine Safety Appliances raises dividend 4 percent

May 11, 2011 1:45 pm | by The Associated Press | Comments

Mine Safety Appliances Co. said Wednesday its board raised the company's regular quarterly dividend to 26 cents from 25 cents.The 4 percent increase is payable June 10 to shareholders of record on May 23.The board of the maker of safety products for workers and consumers also declared a...

Noveko International reports third quarter loss narrows 47 per cent

May 11, 2011 12:45 pm | by The Associated Press | Comments

Noveko International Inc. (TSX:EKO), a Montreal-based medical equipment maker, reports its net loss fell 47 per cent in the third quarter to $2.7 million from $5.2 million. Consolidated revenues for the quarter ended March 31 grew by 17 per cent to $3.4 million.

Advertisement

Halozyme, ViroPharma sign $83M licensing deal

May 11, 2011 11:45 am | by The Associated Press | Comments

Biotechnology company Halozyme Therapeutics Inc. said Wednesday it could receive up to $83 million from ViroPharma Inc. under a licensing agreement for the development of an injectable version of the drug Cinryze, which aims to prevent the genetic disease hereditary angioedema.Halozyme, which is...

Doctors in Germany Among First to Use New Self-Expanding Clot Removal Device for Ischemic Stroke

May 11, 2011 11:33 am | by Bio-Medicine.Org | Comments

RAYNHAM, Mass., May 11, 2011 /- Doctors in Germany are among the first to treat ischemic stroke patients outside the United States with the REVIVE™ SE, a new self-expanding blood clot retrieval and removal device designed to remove blood clots and restore blood flow to the brain in...

TOPICS:

Convicted health exec's art holdings up for bid

May 11, 2011 8:45 am | by The Associated Press | Comments

The art collection of disgraced health care executive Richard Scrushy is going on the auction block, with proceeds going to his former company and its shareholders.The collection owned by the former HealthSouth CEO will be sold off Sunday by Freeman's, a 206-year-old auction house in downtown...

HCB Health Wins Manny Award for Best Medical Device Campaign

May 11, 2011 8:36 am | by Bio-Medicine.Org | Comments

AUSTIN, Texas, May 11, 2011 /- HCB Health, one of the top 25 independent healthcare communications agencies in the nation and the leading healthcare agency in the Southwest, won a Manny Award for best medical device campaign in the 22nd annual Manny Awards, a national competition honoring...

TOPICS:

Fredericksburg Nephrology Associates, Inc., Successfully Attests to Meaningful Use Using Acumen EHR

May 11, 2011 8:36 am | by Bio-Medicine.Org | Comments

NASHVILLE, Tenn., May 11, 2011 /- Health IT Services Group (HITSG) announced that on Monday, April 18, 2011, Fredericksburg Nephrology Associates, Inc. (FNA) in Fredericksburg, Virginia, successfully attested to meaningful use using Acumen nEHR version 6.0. Fredericksburg Nephrology,...

TOPICS:
Advertisement

Brain focused BeCaid joins incubator

May 11, 2011 8:35 am | by Mass High Tech: The Journal of New England Technology | Comments

Yale University spinout BeCaid LLC, which is working on brain development programs that are tied to physical exercise, has become the latest member of Connecticut Innovations' CTech@Science Park incubator at Yale in New Haven, Conn.

TOPICS:

Animas and LifeScan Strengthen Strategic Focus to Better Serve People Living with Diabetes

May 11, 2011 8:35 am | by Bio-Medicine.Org | Comments

WEST CHESTER, Pa., May 11, 2011 /- Animas Corporation and LifeScan, Inc., both members of the Johnson & Johnson Family of Diabetes Companies, today announced plans to further build upon their existing collaborative efforts to co-develop and market innovative new products and tools for...

TOPICS:

Boston Scientific Announces Favorable Jury Verdict Against Cordis Corporation in Stent Patent Litigation

May 11, 2011 8:34 am | by Bio-Medicine.Org | Comments

NATICK, Mass., May 11, 2011 /- Boston Scientific Corporation (NYSE: BSX ) today announced that a jury in the District Court for the District of Delaware found that Cordis Corporation owed Boston Scientific approximately $19.5 million for infringing its Jang patent, which covers...

TOPICS:

Amira Pharmaceuticals to Present Preclinical Data on AM152 , an LPA1 Receptor Antagonist, at the Annual Meeting of the American Thoracic Society

May 11, 2011 8:33 am | by Bio-Medicine.Org | Comments

SAN DIEGO, May 11, 2011 /- Amira Pharmaceuticals, Inc. announced today that it will present preclinical data on AM152, an LPA1 receptor antagonist, during the Annual Meeting of the American Thoracic Society (ATS) in Denver, Colorado.  The poster, titled "The LPA1 Antagonist, AM152,...

TOPICS:

Healthpoint Biotherapeutics Introduces OASIS® Ultra Tri-Layer Matrix

May 11, 2011 7:39 am | by Bio-Medicine.Org | Comments

FORT WORTH, Texas, May 11, 2011 /- Healthpoint Biotherapeutics today announced the introduction of OASIS® Ultra Tri-Layer Matrix, a natural extracellular matrix (ECM) material derived from three layers of porcine small intestinal submucosa (SIS). The three-layer construct of ECM was...

TOPICS:

Prexa releases details on $7M funding

May 11, 2011 7:38 am | by Mass High Tech: The Journal of New England Technology | Comments

Prexa Pharmaceuticals today revealed that Shire Pharmaceuticals was among the investors in Prexa's $7 million Series B financing, which was first reported in a filing with the U.S. Securities and Exchange Commission in late April.

TOPICS:

Draft Guidance for Industry and Food and Drug Administration Staff - Establishing the Performance Characteristics of In Vitro Diagnostic Devices for Chlamydia trachomatis and/...

May 11, 2011 6:32 am | by U.S. Food & Drug Administration | Comments

These devices are used to aid in the diagnosis of urogenital C. trachomatisand/or N. gonorrhoeae infection. They include devices that detect one specific organism, as well as devices that may detect both organisms with or without further differentiation.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading